BIOMAT Database Logo BIOMAT Database Logo

Partial characterization of epidermal protein kinase C in mice sensitive or resistant to phorbol ester. 1990

N Hirabayashi, and B S Warren, and X J Wang, and S Petersen-Marht, and L Beltran, and M M Davis, and C L Ashendel, and J DiGiovanni
Department of Carcinogenesis, University of Texas M.D. Anderson Cancer Center, Smithville 78957.

The present study has characterized several aspects of the mouse epidermal protein kinase C (PKC) system and compared phorbol ester-sensitive and -resistant mice. Protein immunoblots of partially purified epidermal PKC preparations from SENCAR and C57BL/6 mice indicated the presence of the gamma-, beta-, and alpha-isozymes of PKC in both strains. Hydroxylapatite chromatography profiles of epidermal PKC isozymes from SENCAR and C57BL/6 mice revealed three major peaks of PKC activity eluting in fractions similar to those observed in chromatograms of brain tissue and corresponding to PKC-gamma, -beta, and -alpha. Further analyses of hydroxylapatite chromatography fractions revealed that PKC-gamma and -beta were present in approximately similar proportions and were much more abundant than PKC-alpha. This distribution of epidermal PKC isozymes was similar in both strains. After a single topical application of 3.4 nmol 12-O-tetradecanoylphorbol-13-acetate (TPA) to SENCAR mouse epidermis, total PKC activity in the cytosol fraction decreased rapidly to about 50% of control within 15 min and was accompanied by an increase (approximately 150% of control) of PKC activity in the membrane fraction. At 4 h, PKC activities were significantly lower than the control levels and remained downregulated through 96 h with a maximal decrease (to approximately 25-30% of the control) in both cytosol and membrane fractions at h. PKC activity returned to control levels by 168 h. Ca++/phospholipid-independent kinase activity was the same as control levels at 15 min, 1 h, and 4 h after TPA treatment but was elevated above control levels at 24 h, 48 h, and 96 h, and by 168 h returned essentially to control levels. No differences were found in the magnitude or kinetics of TPA-induced translocation and downregulation of total PKC or appearance of Ca++/phospholipid-independent kinase activity between SENCAR, DBA/2, and C57BL/6 mice. Scatchard analyses using a two binding site model revealed that the apparent Kd and Bmax values for binding of PDBu to epidermal cytosol and membrane fractions were similar between SSln, SENCAR, DBA/2, and C57BL/6 mice. The present results demonstrate for the first time that mouse epidermis contains significant amounts of the three major PKC isozymes that are present in brain, especially PKC-gamma. In addition, topical application of a promoting dose of TPA did not lead to complete loss of PKC activity in either the membrane or cytosol fractions of mouse epidermis. In conclusion, no differences were observed between phorbol ester-sensitive and -resistant mice in any aspect of epidermal PKC examined.

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D011493 Protein Kinase C An serine-threonine protein kinase that requires the presence of physiological concentrations of CALCIUM and membrane PHOSPHOLIPIDS. The additional presence of DIACYLGLYCEROLS markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by PHORBOL ESTERS and it is believed that protein kinase C is the receptor protein of tumor-promoting phorbol esters. Calcium Phospholipid-Dependent Protein Kinase,Calcium-Activated Phospholipid-Dependent Kinase,PKC Serine-Threonine Kinase,Phospholipid-Sensitive Calcium-Dependent Protein Kinase,Protein Kinase M,Calcium Activated Phospholipid Dependent Kinase,Calcium Phospholipid Dependent Protein Kinase,PKC Serine Threonine Kinase,Phospholipid Sensitive Calcium Dependent Protein Kinase,Phospholipid-Dependent Kinase, Calcium-Activated,Serine-Threonine Kinase, PKC
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D001692 Biological Transport The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments. Transport, Biological,Biologic Transport,Transport, Biologic
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species

Related Publications

N Hirabayashi, and B S Warren, and X J Wang, and S Petersen-Marht, and L Beltran, and M M Davis, and C L Ashendel, and J DiGiovanni
Phorbol ester activation of epidermal protein kinase C from tumor promotion sensitive and resistant mouse strains.
November 1985, Cancer letters,
N Hirabayashi, and B S Warren, and X J Wang, and S Petersen-Marht, and L Beltran, and M M Davis, and C L Ashendel, and J DiGiovanni
Characterization of phorbol ester binding to protein kinase C isotypes.
August 1995, Molecular pharmacology,
N Hirabayashi, and B S Warren, and X J Wang, and S Petersen-Marht, and L Beltran, and M M Davis, and C L Ashendel, and J DiGiovanni
Protein kinase C isozyme expression in phorbol ester-sensitive and -resistant EL4 thymoma cells.
March 1991, The Journal of biological chemistry,
N Hirabayashi, and B S Warren, and X J Wang, and S Petersen-Marht, and L Beltran, and M M Davis, and C L Ashendel, and J DiGiovanni
Effects of protein kinase C activators on phorbol ester-sensitive and -resistant EL4 thymoma cells.
September 1997, Carcinogenesis,
N Hirabayashi, and B S Warren, and X J Wang, and S Petersen-Marht, and L Beltran, and M M Davis, and C L Ashendel, and J DiGiovanni
Selective up-regulation of protein kinase C eta in phorbol ester-sensitive versus -resistant EL4 mouse thymoma cells.
June 1997, Cancer research,
N Hirabayashi, and B S Warren, and X J Wang, and S Petersen-Marht, and L Beltran, and M M Davis, and C L Ashendel, and J DiGiovanni
Loss of mouse epidermal protein kinase C isozyme activities following treatment with phorbol ester and non-phorbol ester tumor promoters.
December 1994, Carcinogenesis,
N Hirabayashi, and B S Warren, and X J Wang, and S Petersen-Marht, and L Beltran, and M M Davis, and C L Ashendel, and J DiGiovanni
Tumorigenic and molecular characterization of novel phorbol ester-resistant and -sensitive lines of mice.
January 1988, Molecular carcinogenesis,
N Hirabayashi, and B S Warren, and X J Wang, and S Petersen-Marht, and L Beltran, and M M Davis, and C L Ashendel, and J DiGiovanni
Mediation of phorbol ester-induced oxidant generation in murine epidermal cells by protein kinase C.
January 1989, Toxicology in vitro : an international journal published in association with BIBRA,
N Hirabayashi, and B S Warren, and X J Wang, and S Petersen-Marht, and L Beltran, and M M Davis, and C L Ashendel, and J DiGiovanni
Expression of protein kinase C isoforms in HL60 and phorbol ester resistant HL525 cells.
January 1993, Cytobios,
N Hirabayashi, and B S Warren, and X J Wang, and S Petersen-Marht, and L Beltran, and M M Davis, and C L Ashendel, and J DiGiovanni
Protein kinase C negatively modulated by phorbol ester.
July 1986, FEBS letters,
Copied contents to your clipboard!